N1,N2-Di-tert-butylethane-1,2-diamine Cas:4062-60-6

We are N1,N2-Di-tert-butylethane-1,2-diamine CAS:4062-60-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


N1,N2-Di-tert-butylethane-1,2-diamine

Synonyms:
N1,N2-Di-tert-butylethane-1,2-diamine
N,N‘-Di-tert-butylethanediamine
N,N′-Di-tert-butylethylenediamine
N,N'-Di-tert-butylethylenediamine
N,N'-ditert-butylethane-1,2-diamine
1,2-Bis(tert-butylamino)ethane
 
molecular formula: C10H24N2
Molecular weight: 172.31100
 
 
Physical Properties:
Appearance and properties: colorless to yellow liquid
Density: 0.799 g/mL at 25 °C(lit.)
Boiling point: 196-198 °C(lit.)
Flash Point: 144°F
Refractive index: n20/D 1.43(lit.)
Vapor Pressure: 0.21mmHg at 25°C
 
Specification:
Item Standard Test Results
Identification A.H-NMR:Comply with the structure Complies
B.LC-MS:Comply with the structure Complies
C.The IR spectrum of sample should be identical with that of reference standard. Complies
D.HPLC-ESI-MS
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Complies
Loss on drying ≤2.0% 0.19%
Heavy metals ≤10 ppm <10ppm
Water ≤1.0% 0.1%
Sulphated ash ≤0.5% determined on 1.0 g. 0.009%
Residue on ignition ≤0.1% 0.03%
Related Substances Unspecified impurities: for each impurity ≤0.10% <0.10%
Total Impurity ≤0.5% 0.18%
Purity ≥99.0% 99.7%
Assay 99.0%~101.0% (anhydrous substance). 99.8%
Storage Preserve in well-closed, light-resistant and airtight containers. Complies
 

Application:
Organic intermediate
 
Package and Storage:
25kgs/Drum



Market News:Moreover, the improved stereoselectivity further enhances product purity by ensuring that only one stereoisomer reacts where a mixture of stereoisomers is present. Dehydrogenase, reduced nicotinamide adenine dinucleotide(Nicotiana cordifolia plastid gene ndhF subunit F fragment) manufacturer.The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. (1α,1aα,2α,7α,7aα)-1a,2,7,7a-tetrahydro-2,7-epoxy-1H-cyclopropa(b)-naphthalene-1-carbaldehyde supplier.Moderna filed an application with the FDA for that same younger age group on June 10 but has yet to hear from the agency. States like Rhode Island have already signed off on allowing 12 to 17-year-olds to use the vaccine. (S)-5-[(2-t-butoxycarbonylamino-4-methyl)-pentyl]-2,2-dimethyl-1,3-dioxane-4,6-dione producer.

Related Products
Product Name
1-hexyl-2,3-dimethylimidazolium hexafluorophosphate View Details
(1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxylate 4-methylbenzenesulfonate View Details
2,3-Difluorophenylboronic acid View Details
3-(tert-Butyldimethylsilyloxy)glutaric anhydride manufacturer 9-Iodo-1-nonanol manufacturer 2-Fluoro-6-iodobenzonitrile manufacturer 4-[(3-fluorophenyl)methoxy]benzaldehyde manufacturer 3,4-Hexanedione manufacturer